In vitro activity of clindamycin, doxycycline, and trimethoprim/sulfamethoxazole against clinical isolates of β-hemolytic Streptococcus spp. via BD Phoenix and broth microdilution

• Main Authors: Christian Cho (Author), Ryan K Shields (Author), Ellen G Kline (Author), Thomas L. Walsh (Author), Chelsea E. Jones (Author), Karen Kasarda (Author), Kelly Stefano (Author), Matthew A. Moffa (Author), Derek N. Bremmer (Author)
• Format: Book
• Published: Cambridge University Press, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We tested 85 isolates of β-hemolytic Streptococcus spp. against trimethoprim/sulfamethoxazole (TMP/SMX), clindamycin, and doxycycline by broth microdilution (BMD) and BD Phoenix. Susceptibility rates via BMD for TMP/SMX, clindamycin, and doxycycline were 100%, 85.5%, and 56.6%, respectively. TMP/SMX...